Galecto Biotech66% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- At least one vc investor: Sunstone Life Science Ventures
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
OxThera66% | - Similar verticals: Biotech, Pharma
- Similar business models: B2B
- At least one vc investor: Sunstone Life Science Ventures
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Forendo Pharma66% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- At least one vc investor: Sunstone Life Science Ventures
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Orphazyme65% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Sunstone Life Science Ventures
- At least one other investor: Novo A/S
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
MinervaX56% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- At least one vc investor: Sunstone Life Science Ventures
- Total raised in a similar range: 10M+ USD
|
Acarix55% | - Similar verticals: Health services
- Similar business models: B2B
- At least one vc investor: Sunstone Life Science Ventures
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Snipr Biome55% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Wellington Partners
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
NMD Pharma54% | - Similar verticals: Biotech, Health services, Pharma
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Aprea Therapeutics54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Alvotech54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Asarina Pharma54% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
AFYX Therapeutics54% | - Similar verticals: Biotech, Health services, Pharma
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Mobidiag54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Unibio54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
ITBMed54% | - Similar verticals: Biotech, Health services, Pharma
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Oncoinvent54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
InProTher44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- At least one other investor: Novo A/S
|
TILT Biotherapeutics44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
Vaccibody44% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
|
Optomed44% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Minim one investor from outside Scandinavia: Yes
|